The U.S. Judicial Panel on Multidistrict Litigation will hear oral arguments on March 29 in Dan Diego regarding the centralization of all Propecia lawsuits filed by men who used the Merck & Co. hair loss drug and developed permanent or persistent erectile dysfunction and other issues.
According to the more than 50 lawsuits filed in federal courts across the country, Merck failed to warn physicians and patients about the long-term side effects of Propecia, including sexual dysfunction, depression, anxiety, infertility, and loss of libido.
The warning label on Propecia sold in the United States says the side effects are temporary based on clinical trial observations that showed that side effects resolved after use of the medication was stopped. However, in many other countries, the warning label for Propecia includes information that side effects could be persistent, even after the medication was discontinued.
Merck claims that because most of the lawsuits were filed in New Jersey, the cases should be consolidated there. At least one plaintiff wants the lawsuits consolidated to the U.S. District Court for the Eastern District of New York.